Collaborations

Biotech enters partnership with Institute for Cancer Prevention to fight cancer

Published in Cancer Weekly, February 3rd, 2004

Integrated BioPharma, Inc., (INB) has entered into a collaborative agreement with The Institute for Cancer Prevention, Inc., (IFCP).

INB and IFCP will jointly research, develop, and test compounds for anticarcinogenic activity. Under the agreement, INB has the exclusive rights to commercialize the compounds resulting from the research and development collaboration. The Institute will receive a royalty for each compound commercialized by INB as a result of the collaboration.

The initial evaluation in this collaboration will focus on selenium compounds as cancer preventive materials. These compounds are produced using the proprietary, plant-based...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-02-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry